DeePathology® STUDIO
DIY AI platform for pathologists to develop custom AI solutions for histological image analysis on their own laptop
Company profile
Company profile
DeePathology is a health AI company specializing in artificial intelligence solutions for digital pathology and laboratory diagnostics. The company's flagship product, DeePathology® STUDIO, is an interactive do-it-yourself platform that empowers pathologists and researchers to develop custom AI algorithms for histological image analysis without requiring programming expertise. The platform leverages state-of-the-art deep learning and neural networks to enable rapid creation of proof-of-concept solutions, often within minutes, using minimal training data. DeePathology® STUDIO supports multiple analysis modes including object segmentation, cell detection and classification, region segmentation, and tile classification. The platform's innovative Deep Interactive Online Active Learning approach allows users to annotate thousands of cells in days rather than weeks, dramatically accelerating dataset creation. The software runs locally on users' computers, ensuring data privacy and security without requiring slides to be sent to remote servers. Beyond its DIY platform, DeePathology offers ready-to-use AI applications including diagnostic decision support systems for Helicobacter pylori detection in gastric biopsies and tuberculosis detection in tissue samples. The company also provides professional R&D services for custom algorithmic challenges such as drug outcome prediction and visual search engines. DeePathology serves academic researchers, pathology labs, and healthcare institutions globally, with particular focus on applications in oncology, neuropathology, and infectious disease diagnostics. The company supports all major whole slide imaging formats and integrates with existing pathology workflows.
Company description DeePathology official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Hybrid · On Premise · Other deployment with recorded integration context.
Company milestones
Development of H. Pylori Decision Support System and TB Decision Support System; multiple academic collaborations
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
DIY AI platform for pathologists to develop custom AI solutions for histological image analysis on their own laptop
AI screening tool for detecting Helicobacter Pylori bacteria in gastric biopsies with 100% sensitivity
Custom AI R&D services for pathology challenges including drug outcome prediction and visual search engines
AI detector for identifying tuberculosis in biopsies within 10 seconds
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
No linked records are currently available.
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
H. Pylori Decision Support System designed as screening tool
TB detection in slides (vs 40-60 minutes manual examination)
Annotate in 10 minutes what would take days; thousands of cells in days vs weeks
Create PoC solutions for most problems in 5 minutes
Development of automated Helicobacter Pylori detection in gastric biopsies
First ever automated H. Pylori detector software on gastric biopsies with 100% sensitivity, scanning entire slides within seconds
H&E TMA analysis for cell density quantification in tumor regions
Successful creation of AI algorithms for powerful analytics like cell density in tumor regions
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on DeePathology's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies applying AI to digital pathology, histopathology slide analysis, laboratory diagnostics, or biomarker discovery. Includes AI-powered interpretation of lab test results, at-home diagnostic devices with AI analysis, and platforms that analyze tissue samples or biological specimens to support clinical diagnosis.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.